Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan;23(1):28-32.
doi: 10.2450/BloodTransfus.971. Epub 2024 Dec 19.

Managing preoperative anemia: EPO is needed

Emmanuel Rineau  1   2 , Maëva Campfort  1   2 , Sigismond Lasocki  1   2
Affiliations

Managing preoperative anemia: EPO is needed

Emmanuel Rineau et al. Blood Transfus. 2025 Jan.
No abstract available

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST: ER and SL received personal fees and non-financial support for conferences from CSL Vifor (Paris La Défense, France), Masimo (Neuchâtel, Swizterland) and Pfizer (Paris, France). SL received personal fees and non-financial support from Pharmacosmos (Holbaek, Denmark). ER received honoraria from the French National Authority for Health (HAS) as a project manager for drafting the 2022 French guidelines on perioperative blood management. MC declares that she has no conflicts of interest.

Figures

Figure 1
Figure 1
Proposal of a decision-making algorithm specifying the place of EPO in the management of preoperative anemia, based on research findings and recommendations 1. In a patient with cancer, a benefit-risk discussion regarding the use of EPO should take place, and it is currently suggested to avoid attempting to exceed a hemoglobin level of 12 g/dL with EPO, to limit the thrombotic risk. 2. In a patient with both low iron stores (ferritin <100 μg/L) and anemia of inflammation (C-reactive protein >5 mg/L and transferrin saturation <20%), an EPO treatment may be added if IV iron alone fails to reach the target hemoglobin level. 3. Other treatments depend on the cause of anemia (for example, folate or B12 deficiency). The diagnosis may require an anemia specialist referral. Of note, the cause of anemia should also be investigated in cases of EPO or iron treatment (e.g., gastrointestinal or gynecological bleeding). EPO: erythropoietin; IV: intravenous; TSAT: transferrin saturation.
See this image and copyright information in PMC

References

    1. Abraham D, Leviner DB, Ronai T, Schwartz N, Levi A, Sharoni E. Effect of perioperative erythropoietin on postoperative morbidity and mortality after cardiac surgery: a meta-analysis of randomized controlled trials. Anaesth Crit Care Pain Med. 2024;43:101428. doi: 10.1016/j.accpm.2024.101428. - DOI - PubMed
    1. Cho BC, Serini J, Zorrilla-Vaca A, Scott MJ, Gehrie EA, Frank SM, et al. Impact of preoperative erythropoietin on allogeneic blood transfusions in surgical patients: results from a systematic review and meta-analysis. Anesth Analg. 2019;128:981–992. doi: 10.1213/ANE.0000000000004005. - DOI - PubMed
    1. Kaufner L, von Heymann C, Henkelmann A, Pace NL, Weibel S, Kranke P, et al. Erythropoietin plus iron versus control treatment including placebo or iron for preoperative anaemic adults undergoing non-cardiac surgery. Cochrane Database Syst Rev. 2020;8:CD012451. doi: 10.1002/14651858.CD012451.pub2. - DOI - PMC - PubMed
    1. Kei T, Mistry N, Curley G, Pavenski K, Shehata N, Tanzini RM, et al. Efficacy and safety of erythropoietin and iron therapy to reduce red blood cell transfusion in surgical patients: a systematic review and meta-analysis. Can J Anaesth. 2019;66:716–731. doi: 10.1007/s12630-019-01351-6. - DOI - PubMed
    1. Muñoz M, Gómez-Ramírez S, Campos A, Ruiz J, Liumbruno GM. Pre-operative anaemia: prevalence, consequences and approaches to management. Blood Transfus. 2015;13:370–379. doi: 10.2450/2015.0014-15. - DOI - PMC - PubMed

LinkOut - more resources